Industry News/Clinical Trials

Tumor-Cell Depletion Trial Study on CLL Begun

Published in Gene Therapy Weekly, May 22nd, 1995

CellPro Inc. and the Fred Hutchinson Cancer Research Center, both of Seattle, Washington, announced that they had begun a pilot clinical trial in patients with chronic lymphocytic leukemia (CLL).

The study is designed to demonstrate that the ability of CellPro's Ceprate SC Stem Cell Concentration System to positively select CD34 antigen-expressing stem cells from peripheral blood also results in a significant depletion of tumor cells from the resulting stem cell transplant.

The principal investigator for the study is Peter A. McSweeney, M.D., associate in clinical research at the Hutchinson Center. Primary objectives of the 15-patient pilot trial...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1995-05-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry